Plain-English translation of NCT06560606 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
UCAN CAN-DU is a large research study that follows children with juvenile idiopathic arthritis (JIA) to learn how to personalize treatment for each child. Researchers will collect blood samples, medical information, and answers to questions about how the disease affects your child's life. The goal is to create tools that help doctors predict which treatments will work best and when it's safe to stop treatment.
Right now, doctors treat childhood arthritis with a trial-and-error approach, trying different medications until they find what works for each child. This study exists to find patterns that help predict treatment success upfront, reduce unnecessary treatments, and improve quality of life by getting children into remission faster and more safely.
You likely qualify if…
You likely don't qualify if…
Depending on which group your child joins, you will have regular clinic visits where blood samples are collected, medical information is recorded, and your child completes questionnaires about symptoms and quality of life. The study uses a secure online system to store this information. Your participation will continue over months to years as researchers track how your child responds to treatment and disease progression.
AI-generated summary from trial data · Aug 20, 2026 · Not medical advice
Canada